NLRP1, NLRP3, NLRC4, NLRP6, and AIM2 have been demonstrated to influence the pathogenesis of cancer by modulating innate and adaptive immune responses, cell death, and proliferation [41]. This evidence concerns the gene NLRC4 and cancer.